SCYNEXIS, Inc. Research and Development Expense
SCYNEXIS, Inc. (SCYX) reported Research and Development Expense of $3.89 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentExpense · last filed 2026-08-10
- SCYNEXIS, Inc. research and development expense for the quarter ending 2026-06-30 was $3.89M, a 45.51% decline year-over-year.
- SCYNEXIS, Inc. research and development expense for the quarter ending 2026-03-31 was $12.35M, a 140.25% increase year-over-year.
- SCYNEXIS, Inc. research and development expense for the quarter ending 2025-12-31 was $4.54M, a 5.35% increase year-over-year.
- SCYNEXIS, Inc. research and development expense for the quarter ending 2025-09-30 was $5.45M, a 32.47% decline year-over-year.
- SCYNEXIS, Inc. research and development expense for fiscal 2025 was $22.28M, a 15.62% decline from fiscal 2024.
- SCYNEXIS, Inc. research and development expense for fiscal 2024 was $26.41M, a 14.62% decline from fiscal 2023.
- SCYNEXIS, Inc. research and development expense for fiscal 2023 was $30.93M, a 13.46% increase from fiscal 2022.
- SCYNEXIS, Inc. research and development expense for fiscal 2022 was $27.26M, a 14.66% increase from fiscal 2021.
| Period end | Research and Development Expense 3 month | Research and Development Expense 3 month as first filed | Research and Development Expense 6 month | Research and Development Expense 9 month | Research and Development Expense 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | $3.89M 10-Q · filed 2026-08-10 | $16.24M 10-Q · filed 2026-08-10 | $20.79M derived: sum of 3 quarters · filed 2026-08-10 | $26.24M derived: sum of 4 quarters · filed 2026-08-10 | |
| 2026-03-31 | $12.35M 10-Q · filed 2026-05-11 | $16.90M derived: sum of 2 quarters · filed 2026-05-11 | $22.35M derived: sum of 3 quarters · filed 2026-05-11 | $29.49M derived: sum of 4 quarters · filed 2026-08-10 | |
| 2025-12-31 | $4.54M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-04 | $10.00M derived: sum of 2 quarters · filed 2026-03-04 | $17.14M derived: sum of 3 quarters · filed 2026-08-10 | $22.28M 10-K · filed 2026-03-04 | |
| 2025-09-30 | $5.45M 10-Q · filed 2025-11-05 | $12.59M derived: sum of 2 quarters · filed 2026-08-10 | $17.73M 10-Q · filed 2025-11-05 | $22.05M derived: sum of 4 quarters · filed 2026-08-10 | |
| 2025-06-30 | $7.14M 10-Q · filed 2026-08-10 | $12.28M 10-Q · filed 2026-08-10 | $16.60M derived: sum of 3 quarters · filed 2026-08-10 | $24.67M derived: sum of 4 quarters · filed 2026-08-10 | |
| 2025-03-31 | $5.14M 10-Q · filed 2026-05-11 | $9.46M derived: sum of 2 quarters · filed 2026-05-11 | $17.53M derived: sum of 3 quarters · filed 2026-05-11 | $24.34M derived: sum of 4 quarters · filed 2026-05-11 | |
| 2024-12-31 | $4.31M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-04 | $12.39M derived: sum of 2 quarters · filed 2026-03-04 | $19.19M derived: sum of 3 quarters · filed 2026-03-04 | $26.41M 10-K · filed 2026-03-04 | |
| 2024-09-30 | $8.07M 10-Q · filed 2025-11-05 | $14.88M derived: sum of 2 quarters · filed 2025-11-05 | $22.09M 10-Q · filed 2025-11-05 | $32.68M derived: sum of 4 quarters · filed 2025-11-05 | |
| 2024-06-30 | $6.81M 10-Q · filed 2025-08-13 | $14.02M 10-Q · filed 2025-08-13 | $24.61M derived: sum of 3 quarters · filed 2025-08-13 | $31.07M derived: sum of 4 quarters · filed 2025-08-13 | |
| 2024-03-31 | $7.21M 10-Q · filed 2025-05-15 | $17.80M derived: sum of 2 quarters · filed 2025-05-15 | $24.26M derived: sum of 3 quarters · filed 2025-05-15 | $31.30M derived: sum of 4 quarters · filed 2025-05-15 | |
| 2023-12-31 | $10.59M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-12 | $17.05M derived: sum of 2 quarters · filed 2025-03-12 | $24.09M derived: sum of 3 quarters · filed 2025-03-12 | $30.93M 10-K · filed 2025-03-12 | |
| 2023-09-30 | $6.47M 10-Q · filed 2024-11-06 | $13.51M derived: sum of 2 quarters · filed 2024-11-06 | $20.34M 10-Q · filed 2024-11-06 | $28.19M derived: sum of 4 quarters · filed 2024-11-06 | |
| 2023-06-30 | $7.04M 10-Q · filed 2024-08-08 | $13.88M 10-Q · filed 2024-08-08 | $21.72M derived: sum of 3 quarters · filed 2024-08-08 | $28.15M derived: sum of 4 quarters · filed 2024-08-08 | |
| 2023-03-31 | $6.83M 10-Q · filed 2024-05-08 | $14.68M derived: sum of 2 quarters · filed 2024-05-08 | $21.11M derived: sum of 3 quarters · filed 2024-05-08 | $28.25M derived: sum of 4 quarters · filed 2024-05-08 | |
| 2022-12-31 | $7.85M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | $14.28M derived: sum of 2 quarters · filed 2024-03-28 | $21.41M derived: sum of 3 quarters · filed 2024-03-28 | $27.26M 10-K · filed 2024-03-28 | |
| 2022-09-30 | $6.43M 10-Q · filed 2023-11-13 | $13.56M derived: sum of 2 quarters · filed 2023-11-13 | $19.41M 10-Q · filed 2023-11-13 | $26.99M derived: sum of 4 quarters · filed 2023-11-13 | |
| 2022-06-30 | $7.13M 10-Q · filed 2023-08-14 | $12.98M 10-Q · filed 2023-08-14 | $20.56M derived: sum of 3 quarters · filed 2023-08-14 | $24.96M derived: sum of 4 quarters · filed 2023-08-14 | |
| 2022-03-31 | $5.74M 10-Q · filed 2023-05-10 | $13.43M derived: sum of 2 quarters · filed 2023-05-10 | $17.83M derived: sum of 3 quarters · filed 2023-05-10 | $22.56M derived: sum of 4 quarters · filed 2023-05-10 | |
| 2021-12-31 | $7.69M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | $12.09M derived: sum of 2 quarters · filed 2023-03-31 | $16.82M derived: sum of 3 quarters · filed 2023-03-31 | $23.77M 10-K · filed 2023-03-31 | |
| 2021-09-30 | $4.40M 10-Q · filed 2022-11-09 | $9.13M derived: sum of 2 quarters · filed 2022-11-09 | $16.08M 10-Q · filed 2022-11-09 | $26.24M derived: sum of 4 quarters · filed 2022-11-09 | |
| 2021-06-30 | $4.73M 10-Q · filed 2022-08-15 | $11.68M 10-Q · filed 2022-08-15 | $21.84M derived: sum of 3 quarters · filed 2022-08-15 | $29.87M derived: sum of 4 quarters · filed 2022-08-15 | |
| 2021-03-31 | $6.95M 10-Q · filed 2022-05-12 | $17.11M derived: sum of 2 quarters · filed 2022-05-12 | $25.14M derived: sum of 3 quarters · filed 2022-05-12 | $33.60M derived: sum of 4 quarters · filed 2022-05-12 | |
| 2020-12-31 | $10.16M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-29 | $18.19M derived: sum of 2 quarters · filed 2022-03-29 | $26.66M derived: sum of 3 quarters · filed 2022-03-29 | $36.52M 10-K · filed 2022-03-29 | |
| 2020-09-30 | $8.03M 10-Q · filed 2021-11-10 | $16.50M derived: sum of 2 quarters · filed 2021-11-10 | $26.36M 10-Q · filed 2021-11-10 | $37.33M derived: sum of 4 quarters · filed 2021-11-10 | |
| 2020-06-30 | $8.47M 10-Q · filed 2021-08-16 | $18.34M 10-Q · filed 2021-08-16 | $29.30M derived: sum of 3 quarters · filed 2021-08-16 | $38.57M derived: sum of 4 quarters · filed 2021-08-16 | |
| 2020-03-31 | $9.87M 10-Q · filed 2021-05-17 | $20.83M derived: sum of 2 quarters · filed 2021-05-17 | $30.10M derived: sum of 3 quarters · filed 2021-05-17 | $38.58M derived: sum of 4 quarters · filed 2021-05-17 | |
| 2019-12-31 | $10.96M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-29 | $20.24M derived: sum of 2 quarters · filed 2021-03-29 | $28.71M derived: sum of 3 quarters · filed 2021-03-29 | $38.39M 10-K · filed 2021-03-29 | |
| 2019-09-30 | $9.28M 10-Q · filed 2020-11-06 | $17.75M derived: sum of 2 quarters · filed 2020-11-06 | $27.43M 10-Q · filed 2020-11-06 | $34.14M derived: sum of 4 quarters · filed 2020-11-06 | |
| 2019-06-30 | $8.47M 10-Q · filed 2020-08-10 | $18.16M 10-Q · filed 2020-08-10 | $24.86M derived: sum of 3 quarters · filed 2020-08-10 | $28.79M derived: sum of 4 quarters · filed 2020-08-10 | |
| 2019-03-31 | $9.68M 10-Q · filed 2020-05-11 | $16.39M derived: sum of 2 quarters · filed 2020-05-11 | $20.32M derived: sum of 3 quarters · filed 2020-05-11 | $25.92M derived: sum of 4 quarters · filed 2020-05-11 | |
| 2018-12-31 | $6.70M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-11 | $10.63M derived: sum of 2 quarters · filed 2020-03-11 | $16.23M derived: sum of 3 quarters · filed 2020-03-11 | $21.56M 10-K · filed 2020-03-11 | |
| 2018-09-30 | $3.93M 10-Q · filed 2019-11-12 | $9.53M derived: sum of 2 quarters · filed 2019-11-12 | $14.86M 10-Q · filed 2019-11-12 | $20.26M derived: sum of 4 quarters · filed 2019-11-12 | |
| 2018-06-30 | $5.60M 10-Q · filed 2019-08-07 | $10.93M 10-Q · filed 2019-08-07 | $16.32M derived: sum of 3 quarters · filed 2019-08-07 | $20.78M derived: sum of 4 quarters · filed 2019-08-07 | |
| 2018-03-31 | $5.33M 10-Q · filed 2019-05-08 | $10.72M derived: sum of 2 quarters · filed 2019-05-08 | $15.18M derived: sum of 3 quarters · filed 2019-05-08 | $19.63M derived: sum of 4 quarters · filed 2019-05-08 | |
| 2017-12-31 | $5.40M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-14 | $9.86M derived: sum of 2 quarters · filed 2019-03-14 | $14.31M derived: sum of 3 quarters · filed 2019-03-14 | $18.33M 10-K · filed 2019-03-14 | |
| 2017-09-30 | $4.46M 10-Q · filed 2018-11-13 | $8.91M derived: sum of 2 quarters · filed 2018-11-13 | $12.93M 10-Q · filed 2018-11-13 | $16.71M derived: sum of 4 quarters · filed 2018-11-13 | |
| 2017-06-30 | $4.45M 10-Q · filed 2018-08-09 | $8.47M 10-Q · filed 2018-08-09 | $12.25M derived: sum of 3 quarters · filed 2018-08-09 | $17.14M derived: sum of 4 quarters · filed 2018-08-09 | |
| 2017-03-31 | $4.02M 10-Q · filed 2018-05-08 | $7.80M derived: sum of 2 quarters · filed 2018-05-08 | $12.69M derived: sum of 3 quarters · filed 2018-05-08 | $19.35M derived: sum of 4 quarters · filed 2018-05-08 | |
| 2016-12-31 | $3.78M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-13 | $8.67M derived: sum of 2 quarters · filed 2018-03-13 | $15.33M derived: sum of 3 quarters · filed 2018-03-13 | $20.08M 10-K · filed 2018-03-13 | |
| 2016-09-30 | $4.89M 10-Q · filed 2017-11-07 | $11.55M derived: sum of 2 quarters · filed 2017-11-07 | $16.29M 10-Q · filed 2017-11-07 | $22.21M derived: sum of 4 quarters · filed 2017-11-07 | |
| 2016-06-30 | $6.66M 10-Q · filed 2017-08-08 | $11.40M 10-Q · filed 2017-08-08 | $17.32M derived: sum of 3 quarters · filed 2017-08-08 | $20.77M derived: sum of 4 quarters · filed 2017-08-08 | |
| 2016-03-31 | $4.74M 10-Q · filed 2017-05-08 | $10.66M derived: sum of 2 quarters · filed 2017-05-08 | $14.12M derived: sum of 3 quarters · filed 2017-05-08 | $17.40M derived: sum of 4 quarters · filed 2017-05-08 | |
| 2015-12-31 | $5.92M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-13 | $9.37M derived: sum of 2 quarters · filed 2017-03-13 | $12.65M derived: sum of 3 quarters · filed 2017-03-13 | $16.44M 10-K · filed 2017-03-13 | |
| 2015-09-30 | $3.46M 10-Q · filed 2016-11-07 | $6.74M derived: sum of 2 quarters · filed 2016-11-07 | $10.53M 10-Q · filed 2016-11-07 | $13.19M derived: sum of 4 quarters · filed 2017-03-13 | |
| 2015-06-30 | $3.28M 10-Q · filed 2016-08-08 | $7.07M 10-Q · filed 2016-08-08 | $9.73M derived: sum of 3 quarters · filed 2017-03-13 | $12.21M derived: sum of 4 quarters · filed 2017-03-13 | |
| 2015-03-31 | $3.79M 10-Q · filed 2016-05-09 | $4.22M 10-Q · filed 2015-05-15 | $6.45M derived: sum of 2 quarters · filed 2017-03-13 | $8.93M derived: sum of 3 quarters · filed 2017-03-13 | $10.75M derived: sum of 4 quarters · filed 2017-03-13 |
| 2014-12-31 | $2.67M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-13 | $5.14M derived: sum of 2 quarters · filed 2017-03-13 | $6.97M derived: sum of 3 quarters · filed 2017-03-13 | $8.29M 10-K · filed 2017-03-13 | |
| 2014-09-30 | $2.48M 10-Q · filed 2015-11-13 | $4.30M derived: sum of 2 quarters · filed 2015-11-13 | $5.62M 10-Q · filed 2015-11-13 | $6.78M derived: sum of 4 quarters · filed 2015-11-13 | |
| 2014-06-30 | $1.82M 10-Q · filed 2015-08-19 | $3.14M 10-Q · filed 2015-08-19 | $4.30M derived: sum of 3 quarters · filed 2015-10-30 | $5.35M derived: sum of 4 quarters · filed 2015-10-30 | |
| 2014-03-31 | $1.32M 8-K · filed 2015-10-30 | $2.48M derived: sum of 2 quarters · filed 2015-10-30 | $3.53M derived: sum of 3 quarters · filed 2015-10-30 | $4.53M derived: sum of 4 quarters · filed 2015-10-30 | |
| 2013-12-31 | $1.16M derived: 8-K 12 month − 10-Q 9 month · filed 2015-10-30 | $2.21M derived: sum of 2 quarters · filed 2015-10-30 | $3.21M derived: sum of 3 quarters · filed 2015-10-30 | $4.36M 8-K · filed 2015-10-30 | |
| 2013-09-30 | $1.05M 10-Q · filed 2014-11-13 | $2.05M derived: sum of 2 quarters · filed 2014-11-13 | $3.20M 10-Q · filed 2014-11-13 | ||
| 2013-06-30 | $999.00K 10-Q · filed 2014-08-13 | $2.15M 10-Q · filed 2014-08-13 | |||
| 2013-03-31 | $1.15M 10-Q/A · filed 2014-07-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| VERU INC. (VERU) | United States | $0.043B | -3.93 |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| Lite Strategy, Inc. (LITS) | United States | $0.049B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |